Analyst Price Target on SRNE Based on 2 analysts giving stock ratings to Sorrento Therapeutics in the past 3 months $22.00 ?(816.67% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Sorrento Therapeutics in the last 3 months. The average price target is $22.00 with a high forecast of $26.00 and a low forecast of $18.00. The average price target represents a 816.67% change from the last price of $2.40.